Phase 1 Diagnostic Tests
The Biosensor Platform uses Organic Thin Film Transistor (OTFT) technology, which can be printed at scale, at a low cost. By substituting the detection element (region A) depending on the analyte to be detected, the Biosensor can be modified to monitor a wide range of saliva-based diagnostic analytes . The Platform is in development to test for up to 130 indications, ranging from glucose to immunological conditions and communicable diseases.
Currently, we are developing two urgently needed innovations using the Biosensor Platform.